Ethyl bromoacetate → HCID 22100695, compound
Reaction equation
[CH3:1][C:2]1[N:6]([CH2:7][C:8]2[C:17]3[C:12](=[CH:13][CH:14]=[CH:15][CH:16]=3)[C:11]([C:18]#[N:19])=[CH:10][CH:9]=2)[C:5]2[CH:20]=[C:21]([O:25][CH:26]3[CH2:31][CH2:30][N:29]([C:32]([O:34][C:35]([CH3:38])([CH3:37])[CH3:36])=[O:33])[CH2:28][CH2:27]3)[C:22]([OH:24])=[CH:23][C:4]=2[N:3]=1.[H-].[Na+].Br[CH2:42][C:43]([O:45][CH2:46][CH3:47])=[O:44].C(OCC)(=O)C>CN(C=O)C.O>[CH3:1][C:2]1[N:6]([CH2:7][C:8]2[C:17]3[C:12](=[CH:13][CH:14]=[CH:15][CH:16]=3)[C:11]([C:18]#[N:19])=[CH:10][CH:9]=2)[C:5]2[CH:20]=[C:21]([O:25][CH:26]3[CH2:31][CH2:30][N:29]([C:32]([O:34][C:35]([CH3:38])([CH3:37])[CH3:36])=[O:33])[CH2:28][CH2:27]3)[C:22]([O:24][CH2:42][C:43]([O:45][CH2:46][CH3:47])=[O:44])=[CH:23][C:4]=2[N:3]=1Participants
7
Reactant 4
Product 1
Reagents, catalysts & solvents 2
Procedure
To 2-methyl-5-hydroxy-6-(N-(tert-butoxycarbonyl)piperidin-4-yloxy)-1-(4-cyanonaphth-1-yl)methylbenzimidazole (1.11 g) in DMF (50 mL) was added NaH (0.15 g) at ambient temperature. After stirring at ambient for 30 minutes ethyl bromoacetate (0.4 mL) was added. The reaction was stirred at ambient temperature for 1 hour and was worked up between ethyl acetate and H2O. The organic layer was dried, concentrated and purified by silica gel chromatography (hexane/ethyl acetate/CH2Cl2 /methanol, gradient) to afford 2-methyl-5-(ethoxycarbonylmethoxy)-6-(N-(tert-butoxycarbonyl)piperidin-4-yloxy)-1-(4-cyanonaphth-1-yl)methylbenzimidazole.
Workup
- additionwas added
- customThe organic layer was dried
- concentrationconcentrated
- custompurified by silica gel chromatography (hexane/ethyl acetate/CH2Cl2 /methanol, gradient)
Sources & evidence
- ORD record
- ord-ebe717e578194262a24b98995e2afe7b
- Source dataset
- uspto-grants-1998_12
- Patent number
- US05849759
Reaction notes
Loading…